These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33102580)

  • 1. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.
    Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G
    Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.
    Ou YJ; Chiu HF; Wong YH; Yang CC; Yang YH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1286-1295. PubMed ID: 28857419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
    Oh YH; Yoon C; Park SM
    World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between bisphosphonate use and stroke risk: a meta-analysis.
    Lin SM; Lin JY; Tu YK; Wu CH; Peng CC; Munir KM; Bukhari K; Jaggon K; Fu Y; Loh CH; Huang HK
    Osteoporos Int; 2023 Sep; 34(9):1625-1636. PubMed ID: 37249610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates use and risk of gastric cancer: an updated meta-analysis of cohort and case-control studies.
    Cai D; Qin J; Chen G; Feng W; Liu J
    Minerva Med; 2017 Oct; 108(5):464-472. PubMed ID: 28466630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer.
    Andrici J; Tio M; Eslick GD
    Aliment Pharmacol Ther; 2012 Oct; 36(8):708-16. PubMed ID: 22966908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
    Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
    Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
    Sun K; Liu JM; Sun HX; Lu N; Ning G
    Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and risk of cancers: a systematic review and meta-analysis.
    Li YY; Gao LJ; Zhang YX; Liu SJ; Cheng S; Liu YP; Jia CX
    Br J Cancer; 2020 Nov; 123(10):1570-1581. PubMed ID: 32901134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials.
    Menshawy A; Mattar O; Abdulkarim A; Kasem S; Nasreldin N; Menshawy E; Mohammed S; Abdel-Maboud M; Gadelkarim M; El Ashal GG; Elgebaly AS
    Support Care Cancer; 2018 Apr; 26(4):1029-1038. PubMed ID: 29387997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
    Bae YS; Chang J; Park SM
    Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure in patients treated with bisphosphonates.
    Grove EL; Abrahamsen B; Vestergaard P
    J Intern Med; 2013 Oct; 274(4):342-50. PubMed ID: 23679231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis.
    Wu J; Zhang Q; Yan G; Jin X
    J Orthop Surg Res; 2018 Aug; 13(1):194. PubMed ID: 30071889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
    Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ
    Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.